Hematopoietic stem cell transplantation and quality of life during the first year of treatment
ABSTRACT Objective: to evaluate the quality of life of adult patients with hematological cancer comparing Hematopoietic Stem Cell Transplantation modalities during the first year of treatment. Method: this is an observational and longitudinal research with 55 participants. Data collection was perf...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidade de São Paulo
2018-10-01
|
| Series: | Revista Latino-Americana de Enfermagem |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692018000100369&lng=en&tlng=en |
| _version_ | 1811268981326086144 |
|---|---|
| author | Angela da Costa Barcellos Marques Ana Paula Szczepanik Celina Angélica Mattos Machado Pâmella Naiana Dias Santos Paulo Ricardo Bittencourt Guimarães Luciana Puchalski Kalinke |
| author_facet | Angela da Costa Barcellos Marques Ana Paula Szczepanik Celina Angélica Mattos Machado Pâmella Naiana Dias Santos Paulo Ricardo Bittencourt Guimarães Luciana Puchalski Kalinke |
| author_sort | Angela da Costa Barcellos Marques |
| collection | DOAJ |
| description | ABSTRACT Objective: to evaluate the quality of life of adult patients with hematological cancer comparing Hematopoietic Stem Cell Transplantation modalities during the first year of treatment. Method: this is an observational and longitudinal research with 55 participants. Data collection was performed in six steps: before transplantation, pancytopenia, before hospital discharge, after 100, 180 and 360 days, in a reference hospital in Brazil for this treatment. The international instruments Quality of Life Questionnaire - Core 30 and Functional Assessment Cancer Therapy - Bone Marrow Transplantation were validated and translated into Portuguese (Brazil). Results: the mean age of participants was 36 years, 65% (n = 36) had leukemia diagnosis and 71% (n = 39) had undergone allogenic transplantation. In the Quality of Life Questionnarie - Core30 instrument, the pain symptom was significant between the first and second stages, and loss of appetite between the third and fourth stages, both in the allogenic group. In the Functional Assessment Cancer Therapy - Bone Marrow Transplantation, the functional well-being domain was significant between the third and fourth stages, also in the allogenic group. Conclusions: although the aggressiveness of treatment affects quality of life, patients consider it satisfactory after the first year. There are few significant differences between autologous and allogenic patients, and both groups have recovered in the course of the process. |
| first_indexed | 2024-04-12T21:33:57Z |
| format | Article |
| id | doaj.art-d2d65aca7ad44df4bbfcb89b3e6ac0f0 |
| institution | Directory Open Access Journal |
| issn | 1518-8345 |
| language | English |
| last_indexed | 2024-04-12T21:33:57Z |
| publishDate | 2018-10-01 |
| publisher | Universidade de São Paulo |
| record_format | Article |
| series | Revista Latino-Americana de Enfermagem |
| spelling | doaj.art-d2d65aca7ad44df4bbfcb89b3e6ac0f02022-12-22T03:15:58ZengUniversidade de São PauloRevista Latino-Americana de Enfermagem1518-83452018-10-0126010.1590/1518-8345.2474.3065S0104-11692018000100369Hematopoietic stem cell transplantation and quality of life during the first year of treatmentAngela da Costa Barcellos MarquesAna Paula SzczepanikCelina Angélica Mattos MachadoPâmella Naiana Dias SantosPaulo Ricardo Bittencourt GuimarãesLuciana Puchalski KalinkeABSTRACT Objective: to evaluate the quality of life of adult patients with hematological cancer comparing Hematopoietic Stem Cell Transplantation modalities during the first year of treatment. Method: this is an observational and longitudinal research with 55 participants. Data collection was performed in six steps: before transplantation, pancytopenia, before hospital discharge, after 100, 180 and 360 days, in a reference hospital in Brazil for this treatment. The international instruments Quality of Life Questionnaire - Core 30 and Functional Assessment Cancer Therapy - Bone Marrow Transplantation were validated and translated into Portuguese (Brazil). Results: the mean age of participants was 36 years, 65% (n = 36) had leukemia diagnosis and 71% (n = 39) had undergone allogenic transplantation. In the Quality of Life Questionnarie - Core30 instrument, the pain symptom was significant between the first and second stages, and loss of appetite between the third and fourth stages, both in the allogenic group. In the Functional Assessment Cancer Therapy - Bone Marrow Transplantation, the functional well-being domain was significant between the third and fourth stages, also in the allogenic group. Conclusions: although the aggressiveness of treatment affects quality of life, patients consider it satisfactory after the first year. There are few significant differences between autologous and allogenic patients, and both groups have recovered in the course of the process.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692018000100369&lng=en&tlng=enQuality of LifeHematopoietic Stem Cell TransplantationBone Marrow TransplantationHematologic NeoplasmsOncology NursingDrug Therapy |
| spellingShingle | Angela da Costa Barcellos Marques Ana Paula Szczepanik Celina Angélica Mattos Machado Pâmella Naiana Dias Santos Paulo Ricardo Bittencourt Guimarães Luciana Puchalski Kalinke Hematopoietic stem cell transplantation and quality of life during the first year of treatment Revista Latino-Americana de Enfermagem Quality of Life Hematopoietic Stem Cell Transplantation Bone Marrow Transplantation Hematologic Neoplasms Oncology Nursing Drug Therapy |
| title | Hematopoietic stem cell transplantation and quality of life during the first year of treatment |
| title_full | Hematopoietic stem cell transplantation and quality of life during the first year of treatment |
| title_fullStr | Hematopoietic stem cell transplantation and quality of life during the first year of treatment |
| title_full_unstemmed | Hematopoietic stem cell transplantation and quality of life during the first year of treatment |
| title_short | Hematopoietic stem cell transplantation and quality of life during the first year of treatment |
| title_sort | hematopoietic stem cell transplantation and quality of life during the first year of treatment |
| topic | Quality of Life Hematopoietic Stem Cell Transplantation Bone Marrow Transplantation Hematologic Neoplasms Oncology Nursing Drug Therapy |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692018000100369&lng=en&tlng=en |
| work_keys_str_mv | AT angeladacostabarcellosmarques hematopoieticstemcelltransplantationandqualityoflifeduringthefirstyearoftreatment AT anapaulaszczepanik hematopoieticstemcelltransplantationandqualityoflifeduringthefirstyearoftreatment AT celinaangelicamattosmachado hematopoieticstemcelltransplantationandqualityoflifeduringthefirstyearoftreatment AT pamellanaianadiassantos hematopoieticstemcelltransplantationandqualityoflifeduringthefirstyearoftreatment AT pauloricardobittencourtguimaraes hematopoieticstemcelltransplantationandqualityoflifeduringthefirstyearoftreatment AT lucianapuchalskikalinke hematopoieticstemcelltransplantationandqualityoflifeduringthefirstyearoftreatment |